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hSMUG1 (human single-stranded selective monofunctional
uracil-DNA glyscosylase) is one of three glycosylases encoded
within a small region of human chromosome 12. Those three
glycosylases, UNG (uracil-DNA glycosylase), TDG (thymine-
DNA glyscosylase), and hSMUG1, have in common the capacity
to remove uracil from DNA. However, these glycosylases also
repair other lesions and have distinct substrate preferences,
indicating that they have potentially redundant but not overlap-
ping physiological roles. Themechanisms by which these glyco-
sylases locate and selectively remove target lesions are not well
understood. In addition to uracil, hSMUG1 has been shown to
remove some oxidized pyrimidines, suggesting a role in the
repair of DNA oxidation damage. In this paper, we describe
experiments in which a series of oligonucleotides containing
purine and pyrimidine analogs have been used to probe mecha-
nisms by which hSMUG1 distinguishes potential substrates.
Our results indicate that the preference of hSMUG1 for mis-
paired uracil over uracil pairedwith adenine is best explained by
the reduced stability of a duplex containing amispair, consistent
with previous reports with Escherichia coli mispaired uracil-
DNA glycosylase. We have also extended the substrate range of
hSMUG1 to include 5-carboxyuracil, the last in the series of
damage products from thymine methyl group oxidation. The
properties used by hSMUG1 to select damaged pyrimidines
include the size and free energy of solvation of the 5-substituent
but not electronic inductive properties. The observed distinct
mechanisms of base selection demonstrated for members of the
uracil glycosylase family help explain how considerable diver-
sity in chemical lesion repair can be achieved.
Three glycosylases that initiate DNA repair via the base exci-
sion repair (BER)2 pathway are found on human chromosome
12. These three glycosylases are designated as UNG, TDG, and
hSMUG1 (1–4). Several groups are currently investigating the
structure and properties of these glycosylases in order to deter-
mine their physiological roles. A common property of these
enzymes is the cleavage of uracil residues from DNA, although
each of the glycosylases repairs additional lesions. Despite low
sequence homology (8%), these three glycosylases share a com-
mon fold and overall architecture (5). Subtle differences in
structure apparently distinguish these repair enzymes with
respect to substrate and context preferences.
UNG is the most active of the glycosylases. UNG recognizes
uracil residues when found in single strand, or double strand
DNA paired with adenine or mispaired with guanine (6); how-
ever, only a small number of other pyrimidines are also targets.
UNG is spliced into two forms, UNG1 and UNG2. UNG1 is
targeted to the mitochondrion, whereas UNG2 is found pri-
marily in the cell nucleus (7). Due to the capacity of UNG to
repair uracil in many contexts, as well as its association with
DNA replication machinery and cell cycle specificity, it is
thought that a primary role for UNG is in the repair of uracil
misincorporated opposite adenine during DNA replication (8,
9). Recent studies also suggest an important role for UNG in
removing uracil residues in DNA generated by activation-in-
duced deaminase as part of somatic hypermutation and class
switch recombination in activated B-cells (10–12).
In contrast to UNG, the related glycosylases hSMUG1 and
TDG appear to target uracil and uracil analogs mispaired with
guanine (3, 13, 14). Although hSMUG1 was originally charac-
terized as a single strand selective glycosylase (13), more recent
studies suggest it is more active on mispaired uracil in duplex
DNA (14), and it has an extended substrate range, removing
several oxidized pyrimidines (15–18), including 5-hydroxym-
ethyluracil (HmU), 5-formyluracil (FoU), and 5-hydroxyuracil
(HoU). TDG appears to act exclusively on duplex substrates,
with a strong preference for mispaired pyrimidines, including
thymine, and a strong preference for damage located in CpG
dinucleotides (19–21). The apparent sequence selectivity of
TDG has led to suggestions that the primary role of TDG is the
repair of deaminated 5-methylcytosine residues in CpG
dinucleotides (20).
In this paper, we have investigated the enzymatic properties
of recombinant human SMUG1 in single-turnover kinetic
assays on a series of oligonucleotide substrates containing
purine and pyrimidine analogs. In the first set of experiments,
the capacity of hSMUG1 to cleave uracil opposite a series of
purine analogs was measured to determine if the preference of
hSMUG1 for mispairs can be attributed to reduced duplex sta-
bility or if hSMUG1 recognizes specific functional groups on
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the purine opposite the target uracil. In the second series of
experiments, a series of 5-substituted uracil analogs was paired
opposite guanine to probe the mechanisms by which hSMUG1
distinguishes potential substrates. This series includes uracil, a
series of oxidatively damaged pyrimidines, and the 5-haloura-
cils, which serve to measure both substituent size and elec-
tronic inductive properties. New to this series is 5-carboxyura-
cil (CaU), the last in the sequence of damage products arising
from oxidation of the thymine methyl group (22–24).
Previous studies with other glycosylases described above
have highlighted the importance of size and electronic induc-
tive properties of 5-substituted pyrimidines in substrate selec-
tion. In contrast, the capacity of hSMUG1 to recognize HmU
but not thymine has been attributed to the hydrophilicity and
hydrogen-bonding capacity of theHmUsubstituent (15–18). In
this paper, selected physical properties have been calculated for
each pyrimidine examined, including solvent-accessible sur-
face area (SASA) and the free energy of solvation in water. The
SASA is introduced as a parameter to define the relative size of
the 5-substituted pyrimidines, whereas the free energy of sol-
vation in water is proposed to describe the capacity of the
5-substituted pyrimidine to interact with or replace water
within the hSMUG1 pyrimidine binding pocket. The observed
kinetic rate constants are compared with the physical proper-
ties of the modified bases and base pairs in order to explain the
mechanisms by which hSMUG1 identifies and distinguishes
target lesions. Our results indicate that the strategies used by
hSMUG1 to select target bases and avoid normal bases contrast
with those of other members of the uracil DNA-glycosylase
family.
MATERIALS ANDMETHODS
Oligonucleotide Synthesis and Characterization
Oligonucleotides were prepared by solid phase synthesis
methods as described previously (25–28). Following synthesis
and deprotection, oligonucleotides were purifiedwith Poly-Pak
II cartridges and were denaturing gel-purified when necessary.
The presence of modified bases was verified by gas chromatog-
raphy/mass spectrometry following acid hydrolysis and con-
version to the trimethylsilyl ethers.
Two sets of oligonucleotides were synthesized. A set of oli-
gonucleotide 24-mers containing uracil with different 5-sub-
stituents (X) and purine analogs (P) was synthesized for
hSMUG1 activity assays (Fig. 1A). Another set of self-comple-
mentary 12-mers containing a uracil and a purine analog was
synthesized for melting temperature (Tm) measurements in
which the target uracil analog was placed within the same
sequence context as in the 24-mer glycosylase assays (Fig. 1B).
A 12-base sequence was selected for the thermodynamic stud-
ies, because the predicted Tm would be within an appropriate
range for UV melting studies (29). The self-complementary
12-mers were designed by keeping the two adjacent bases on
each side of the uracil and purine analog base pair constant and
linking the two five-base fragments in the 53 3 orientation.
MALDI-TOF mass spectrometry analysis and Tm values of
the series of 12-mers examined here have been previously
reported (30). Oligonucleotide duplex thermodynamics
(Gduplex) were measured at 100 mM NaCl, 10 mM sodium
phosphate at pH 7, and Tm values are reported for 28 M
total strand concentration.
Preparation and Characterization of the Ionization Properties
of 5-Carboxy-2-deoxyuridine
Commercially available trifluoromethylthymidine (Sigma)
was hydrolyzed in alkaline solution to 5-carboxy-2-deoxyuri-
dine (31) and purified by silica gel chromatography. The
identity of 5-carboxy-2-deoxyuridine was confirmed by
mass spectrometry. Ionization constants were determined
by spectrophotometric titration as described previously (32).
Cloning and Isolation of hSMUG1
RNA of hSMUG1was isolated fromHeLa S3 cell line (ATCC
catalog number CCL-2.2) using TRIzol reagent according to
instructions provided by themanufacturer (Invitrogen).mRNA
was reverse transcribed by using the SuperScript First-Strand
(Invitrogen) standard protocol. First strand cDNA synthesis
was performed by priming with 20 pmol of oligo(dT) in 20l of
reaction mixture containing 10 mM each of dATP, dCTP,
dGTP, and dTTP, 40 units/l RNase Out recombinant ribonu-
clease inhibitor, and 50 units/l SuperScript II reverse tran-
scriptase. The reverse transcription reaction was stopped by
cooling to 4 °C for 10 min. The resulting cDNAs were then
amplified with Phusion high fidelity DNA polymerase (New
England BioLabs, Beverly, MA) according to the manufactur-
er’s instructions. Thirty-six cycles of PCR (10 s at 98 °C, 30 s at
61 °C, and 30 s at 72 °C) were performed. The sequences of
oligonucleotides used for PCR were designed based on the
cDNAsequence ofAF125182 reported byHaushalter et al. (13).
The following sequences were used: 5-cggcggggatccatgccccag-
gctttcctgct-3 (sense, carries a BamHI restriction site) and
5-cttttccttttgcggccgctcatttcaacagcagtggcag-3 (antisense, car-
ries a NotI restriction site).
After resolution of the products by electrophoresis in 1% aga-
rose gel, the expected 819-bp product was extracted using the
QIAquick gel extraction kit (Qiagen, Valencia, CA) and ligated
into glutathione S-transferase fusion expression vector pGEX-
4T-1 (AmershamBiosciences) previously digested with BamHI
and NotI. Ligated products were electroporated into Esche-
richia coli BL21 Star DE3 (Invitrogen). The plasmid was iso-
lated and purified using a QIAprep SpinMiniprep kit (Qiagen),
and both strands of the insert were confirmed via sequencing
(Davis Sequencing, Inc., Davis, CA) using the primers 5-TTG-
GTGGTGGCGACCATCCTCCAA-3 (pGEXmcs5) and 5-
CTGCATGTGTCAGAGGTTTTCACC-3 (pGEXmcs3).
Purification of Recombinant hSMUG1
To purify hSMUG1 expressed as a recombinant protein in
E. coli, 2 liters of E. coli BL21 Star DE3 carrying the hSMUG1-
glutathione S-transferase construct were grown in LB broth
with 50g/ml ampicillin at 37 °C untilA600 0.6–0.7 and then
induced with 0.2 mM isopropyl--D-thiogalactopyranoside
overnight at 30 °C. The cells were harvested by centrifugation,
resuspended in lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl,
5 mM MgCl2, 0.01% Triton X-100), supplemented with 1 mM
dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and incu-
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bated at room temperature for 30 min. Lysis was then com-
pleted by sonicating the suspension on ice using a Branson
Sonifier Cell Disruptor 200 at six bursts of 10 s each, with a 90-s
interval between pulses. The lysate was clarified by centrifuga-
tion (12,000 rpm for 30 min at 4 °C), and the supernatant was
then mixed with swelled glutathione-agarose beads (Sigma)
and incubated at 4 °C overnight with gentle agitation. The sus-
pensions were centrifuged at 3,000 rpm for 5 min at 4 °C, and
the beadswerewashed twicewith lysis buffer, followed by twice
with thrombin buffer (50 mM Tris, pH 7.4, 150 mMNaCl, 5 mM
MgCl2, 1 mM dithiothreitol).
The recombinant protein glutathione S-transferase-
hSMUG1 was resuspended in 15 ml of thrombin buffer and
then was cleaved with 100 units/ml thrombin (Sigma) at 37 °C
for 1 h and subsequently purified by FPLC using a Superdex 75
column (GE Healthcare). The protein was concentrated using
Centricon YM-10 membranes (Millipore, Billerica, MA). The
protein concentration was determined using the BCA protein
assay reagent kit (Pierce). The protein was analyzed on
NuPAGE 4–12% BisTris gels (Invitrogen) stained with Simply
Blue (Invitrogen) and confirmed by Western blots using pri-
mary hSMUG1 antibody (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA). Furthermore, hSMUG1 was digested with
trypsin following the protocol of Matsudaira (33) and analyzed
by MALDI-TOF mass spectrometry (data not shown) (Bruker
Daltonics, Billerica, MA). To further verify that there was no
E. coli uracil-DNA glycosylase contamination after purifica-
tion, we tested the hSMUG1 recombinant activity in the pres-
ence of a uracil glycosylase inhibitor using a single-stranded
uracil-containing oligonucleotide corresponding to Fig. 1 as a
substrate, and as expected, there was no significant difference
in the amount of excised single-stranded uracil-containing oli-
gonucleotide with or without the addition of uracil glycosylase
inhibitor (data not shown).
Determination of Single-turnover Kinetics on
Oligonucleotide Substrates
Oligonucleotide Labeling and Annealing—5-End radiolabel-
ing was performed using adenosine [-32P]ATP (MP Biomedi-
cal, Costa Mesa, CA) and T4 polynucleotide kinase (New Eng-
land BioLabs, Beverly,MA) under conditions recommended by
the enzyme supplier. Labeled mixtures were subsequently cen-
trifuged through G-50 Sephadex columns (Roche Applied Sci-
ence) to remove excess unincorporated nucleotide. Labeled
single-stranded oligonucleotides were annealed to a 2-fold
molar excess of unlabeled complementary strand in 20 mM
Tris-HCl (pH 8.0), 1 mM EDTA, 1 mM dithiothreitol, 0.1
mg/ml bovine serum albumin, and 100 mM NaCl. The mix-
ture was heated to 95 °C for 5 min and cooled slowly to room
temperature.
Enzymatic Reactions under Single-turnover Conditions—The
cleavage rates were determined under single-turnover condi-
tions. DNA substrates (50 nM) were incubated with 200 nM
hSMUG1 at 37 °C in the reaction buffer containing 20mMTris-
HCl (pH 8.0), 1 mM EDTA, 1 mM dithiothreitol, 0.1 mg/ml
bovine serum albumin, and 100 mM NaCl. At selected time
points 10-l samples were removed and stopped by adding 5l
of 0.1 M NaOH and an equal volume of Maxam-Gilbert loading
buffer (98% formamide, 0.01 M EDTA, 1 mg/ml xylene cyanol,
and 1 mg/ml bromphenol blue) and 1 l (50 pmol) of an unla-
beled complementary oligonucleotide as a reannealing compet-
itor. The backbone was cleaved at the apyrimidinic sites with
NaOHby heating at 95 °C for 30min. For oligonucleotides con-
taining FoU and HoU, reactions were stopped by heating to
75 °C for 5 min and then cooled to room temperature. The
abasic site was cleaved by human AP endonuclease at 37 °C for
1 h in reaction buffer provided by the manufacturer (Trevigen,
Gaithersburg,MD). Reaction samples were electrophoresed on
18% denaturing polyacrylamide gels (8 M urea), and the bands
corresponding to substrate and products were visualized and
quantified using a PhosphorImager (GEHealthcare). The reac-
tion rate constant, kobs, was determined by fitting time course
data to a single exponential (y a(1 abx)) using SigmaPlot
10.0, where a represents the maximum level of product ratio,
and b is the reaction rate constant, kobs.
A rapid quenched flow apparatus (RQF-3; KinTek Corp.,
Austin, TX) was used for reactions requiring a short time
course (53 ms to 200 s, U:G, U:Hx, and U:Pu). Rapid quench
reactions were performed using the standard conditions
described above, except that the reaction volume was 35.5 l,
and 100 l of 50 mM NaOH was used to quench reactions. The
quenched reactions were heated at 95 °C for 30 min to cleave
abasic sites and then dried under reduced pressure. DNA was
redissolved in 20 l of Maxam-Gilbert loading buffer, and 1 l
(50 pmol) of the unlabeled complementary oligonucleotide was
added as a reannealing competitor. Samples were analyzed as
described above.
Computational Methods and Procedures
Free Energy of Solvation—In this work, the recently devel-
oped M06-2X (34) flavor of density functional theory (DFT)
was used to determine the solvation free energy of the various
substituted uracil analogs. M06-2X has been shown recently to
provide good accuracy in predicting the binding energy and
structure of van der Waals complexes (35), since it is a hybrid
DFT functional with 54% Hartree-Fock meta-exchange in the
functional. Thus, the M06 family of DFT functionals describes
aromatic-aromatic interactions accurately without adding
empirical corrections to account for the dispersion term, which
was a limitation of previous DFT functionals, such as LDA,
PW91, PBE, and B3LYP (36–40).
Following Kelly et al. (41), the solvation free energy can be
written as follows,
Gsolv
0 X Gaq
0 X Gvac
0 Xgas (Eq. 1)
whereX represents the pyrimidine of interest andwith the total
solvation free energy being the difference in free energy
between the gas phase electronic structure calculation and the
aqueous phase calculation. These two separate calculations are
performed for each substituted uracil analog (5-substituent 
Br, CH3, I, Cl, F, CHO, COOH, CH2OH, OH, and H), as
described below. At physiological pH, 5-carboxyuracil would
exist predominantly as the ionized carboxylate anion. We find
that the most accurate way to calculate the free energy of sol-
vation is to first calculate the solvation free energy of the neutral
hSMUG1 Substrate Selectivity
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molecule and then apply a correction determined by the differ-
ence between the carboxylate pKa and the pH of the solvent
(42), as discussed below.
Gas Phase Calculations—The M06-2X DFT calculations
used the cc-pVTZ(-f) basis set andwere performedwith the
Jaguar 7.5 quantum chemistry software. In several previous
studies of nitrogen-containing heterocyclic compounds, this
methodology gave results of high accuracy (43) and comparable
with a higher level of theory, such as G3B3 (44). The cc-pVTZ(-
f), which is also denoted as “aug-cc-pVTZ” (for “augmented
correlation-consistent basis set with polarized valence triple-
”), is the cc-pVTZ basis set of Dunning et al. (45, 46). For
5-iodouracil, the effective core potentials were used on the
iodine heavy atom, with the rest of the atoms using the cc-
pVTZ(-f) basis set, and this basis set is denoted
cc-pVTZ-PP(-f).
The standard Gibbs free energy of each substituted uracil
analog in the gas phase (42) is given by the following,
Gsolv
0 Xg E0KXg ZPEXg G03 298Xg (Eq. 2)
where E0K is the total electronic energy at 0 K, ZPE is the zero-
point vibrational energy, and G03298 is the Gibbs free energy
change from 0 to 298 K at 1 atm calculated using the rigid
rotor-harmonic oscillator approximation without scaling.
Solution Phase Calculations—The free energy of solvation of
aromatic compounds inwater can be obtained by couplingDFT
with a Poisson-Boltzmann continuum solvent (43). In this
approach, the solute, described quantum mechanically, is
immersed in a continuum solvent described with a self-consis-
tent reaction field, obtained through numerical solution of the
Poisson-Boltzmann equation. The solute is assigned a dielectric
constant of 1 (a vacuum),whereas the
solute-solvent boundary, described as
the solvent-accessible surface area
(SASA), uses standard atomic radii
taken fromTannor et al. (47, 48). The
following radii were used: 1.9 Å for
sp3-hybridized carbon, 1.6 Å for ni-
trogen and oxygen, and 1.15 Å for
hydrogen. The solvent is character-
ized by a probe radius (1.4 Å in the
case of water) rolled along the solute
boundary and having a constant
dielectric (79.2 forwater). The SASAs
of the various analogs (relative to ura-
cil) are used in Table 1 to include the
effect of the substituent size on
themeasured rate.
The charge distribution of the
solute was represented by atom-
centered point charges adjusted to
reproduce the electrostatic poten-
tial (ESP) derived from the quantum
mechanics electron density. The
cavity term (used to represent the
energy required to create the solute
cavity in the solvent) was calculated
using the empirical relation given in
Ref. 45. Calculations were carried out using both gas phase geom-
etries and geometries optimized in the solvent reaction field.
RESULTS
Oligonucleotides containing a series ofmodified purines and
pyrimidines were prepared and characterized as described pre-
viously (30). Sequences used in this study are shown in Fig. 1.
The free energy of duplex formation for the self-complemen-
tary 12-mer oligonucleotides containing purine and pyrimidine
analogs was determined fromUVmelting studies, and the results
are presented in Table 1. Recombinant hSMUG1 was overex-
pressedandpurifiedasdescribedpreviously (13).Characterization
of the recombinant protein included MALDI-TOF mass spec-
trometry analysis of tryptic peptides (data not shown).
In the first series of experiments, hSMUG1 activity against
uracil pairedwith a series of purineswas investigated. An exam-
ple set of kinetic data is shown in Fig. 2. The measured rate
constants (kobs), determined under single-turnover conditions,
are shown in Table 1. An inverse relationship between the nat-
ural logarithm of the enzymatic rate constant and the free
energy of duplex formationwas observed and is shown in Fig. 3.
In a second set of experiments, hSMUG1 single-turnover
kinetic activity against a series of 5-substituted uracil analogs
wasmeasured (Table 1). In order to understand themechanism
of base selection for the uracil analogs tested, selected proper-
ties were either measured or calculated for each of the uracil
analogs examined in the kinetic studies. Rate constants were
then compared with physical parameters as described below.
The oxidation of the thyminemethyl group results in a series
of damage products, including HmU, FoU, and CaU. Although
hSMUG1 has been shown previously to recognize and remove
FIGURE 1. Sequences of oligonucleotides and structures of uracil analogs used in this study. A, oligonu-
cleotide duplex used for glycosylase assays, in which X represents thymine, uracil, or a 5-substituted uracil
analog and P is a purine. B, sequence of the self-complementary oligonucleotide used for the determination of
duplex stability. C, structures of uracil analogs.
hSMUG1 Substrate Selectivity
15838 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 284•NUMBER 23•JUNE 5, 2009
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on June 22, 2009 
w
w
w
.jbc.org
D
ow
nloaded from
 
HmUandFoU (15–18), it has not yet been testedwithCaU.The
carboxyl group of CaU would be expected to be ionized under
physiological conditions. Ionization of the carboxyl group of
CaU could also have a profound effect upon ionization of the
N3 proton. We therefore prepared 5-carboxy-2-deoxyuridine
by an established method (31) and determined the pKa values
for the 5-carboxyl group and the N3 proton by spectrophoto-
metric titration (32), as shown in Fig. 4.
The measured pKa values are 4.08  0.1 for the 5-carboxyl
group and 9.98  0.1 for the N3 position. Previously, we have
shown that the pKa of theN3 proton of uracil derivatives can be
estimated based upon the inductive
property of the 5-substituent (49).
In the case of CaU, the ionization of
the 5-carboxyl group would influ-
ence the pKa of theN3 proton. If the
5-carboxyl group were unionized, it
would withdraw electron density
from the pyrimidine ring ( meta-
Hammett parameter (m)  0.37)
(50), predicting a pKa for the N3
position of 7.86  0.14. Alterna-
tively, if the carboxyl group were
ionized, it would donate electron
density to the pyrimidine ring, pre-
dicting a pKa for the N3 proton of
9.90  0.14. Upon the basis of the
experimentally determined pKa
value of the 5-carboxyl group, we
would expect it to be predominantly
ionized at physiological pH, result-
ing in an increase in the N3 pKa rel-
ative to 2-deoxyuridine. The meas-
ured value for the pKa of the N3
proton of 9.98 is close to the value of
9.90 predicted from the inductive
property of an ionized carboxyl
group (49).
In a previous study, we demon-
strated that the rate of base cleavage
byMUGwas inversely proportional to the size of the 5-substit-
uent (52). In that study, we examined only spherical substitu-
ents whose size could be estimated from van der Waals radii
and bond lengths. In the current study, we examined several
additional pyrimidines with more complicated 5-substituents.
We therefore determined the SASA of the uracil analogs with
5-substituents as an index of relative size by computational
methods, and the values are presented in Table 1. The 5-formyl
group of FoU can rotate around the 5-position and is found in
either syn or anti conformations, as described previously (51).
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FIGURE 2. Kinetic study of hSMUG1 cleavage of 5-substituted uracil analogues paired with guanine
illustrating the gel electrophoretic assay (left) and time-dependent product ratios (right). Single-turn-
over reactions were performed at 37 °C with 50 nM substrate and 200 nM hSMUG1 in the reaction buffer, as
described under “Materials and Methods.” Top, HmU:G as a substrate; bottom, CaU:G as a substrate.
TABLE 1
Rate constants and physical characteristics for base pairs examined in this study
The values include measured rate constants for hSMUG1 glycosylase cleavage reactions (kobs), melting temperature (Tm) from Refs. 30 and 52, measured free energy of
duplex formation (Gduplex) determined from thermalmelting studies, calculated SASA for pyrimidine bases, and calculated free energy of solvation inwater for pyrimidine
bases. Calculated values for SASA and Gsolv0 correspond to neutral molecules. Calculated values for FoU correspond to the anti conformer. 2AA, 2-aminoadenine; 2AP,
2-aminopurine.
kobs Tm Gduplex SASA Gsolv0
s1 °C kcal mol1 Å2 kcal mol1
U:G 1.34 0.15	 101 49.1 0.1 10.8 0.4 262.69 16.76
U:Hx 6.34 0.82	 101 49.0 0.7 10.4 0.5
U:Pu 8.05 0.55	 102 52.4 0.3 12.1 0.3
U:A 5.78 0.14	 104 64.4 0.5 15.9 0.5
U:2AA 3.83 0.59	 104 66.3 0.5 15.3 0.9
U:2AP 2.93 0.12	 103 61.1 0.1 14.7 0.3
FU:G 4.72 0.16	 103 48.9 0.4 10.9 0.4 273.50 17.20
ClU:G 9.40 0.60	 105 50.4 0.4 11.1 0.2 289.43 16.60
BrU:G 
1.0	 106 50.0 0.3 11.1 0.2 298.05 16.47
IU:G 
1.0	 106 49.9 0.3 11.1 0.4 308.35 16.18
HoU:G 4.14 0.25	 102 49.2 0.4 10.4 0.5 270.02 23.60
T:G 
1.0	 106 50.2 0.1 11.3 0.3 286.95 16.16
HmU:G 3.48 0.18	 102 49.5 0.5 11.1 0.2 299.04 22.54
FoU:G 1.33 0.08	 102 46.3 0.2 9.50 0.2 293.24 19.17
CaU:G 2.58 0.19	 102 49.7 0.4 11.0 0.4 296.81 18.83
hSMUG1 Substrate Selectivity
JUNE 5, 2009•VOLUME 284•NUMBER 23 JOURNAL OF BIOLOGICAL CHEMISTRY 15839
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on June 22, 2009 
w
w
w
.jbc.org
D
ow
nloaded from
 
The anti conformation has been determined to be the preferred
orientation. Therefore, the SASA value for FoU recorded in
Table 1 corresponds to the anti conformer. Although SASA
values have been determined previously for some pyrimidines
(53), these values have not been determined for the entire series
of pyrimidines examined here.
Previous studies have established that hSMUG1 can recog-
nize and remove pyrimidine damage products with 5-substitu-
ents capable of hydrogen bonding that could potentially dis-
place water molecules from the hSMUG1 pyrimidine binding
cleft (15–18). In order to derive amolecular property thatmight
be able to quantitatively predict the capacity of uracil analogs to
bind to hSMUG1, we calculated the free energy of solvation in
water for each substituent, and the corresponding values are
recorded in Table 1. Although the free energy of solvation has
been determined for several of the substituents examined here
in other types ofmolecules (54), the free energy of solvation has
not been previously calculated for the series of 5-substituted
uracil analogs examined here.
As discussed above, the formyl group of FoU can be found in
either syn or anti conformation. Since the anti conformation is
preferred, the free energy of solvation for FoU in Table 1 cor-
responds to the anti conformer. Two of the uracil analogs, HoU
and CaU, have acidic protons and can be ionized under physi-
ological conditions. In our experience, the calculation of the
free energy of solvation of ionized molecules in water is unreli-
able due to the inherent difficulty in obtaining reliable values
for the electrostatics of the charged species. Therefore, a com-
monly applied solution is to accurately calculate the free energy
of solvation for the neutral species and then to apply a correc-
tion factor based upon pKa values and solution pH to account
for ionization,
Gsolv
0 uracilCOO Gsolv
0 uracilCOOH GpKa
0 (Eq. 3)
where
GpKa
0 RT	 ln10	 pH pKa 1.42	 pKa pH
(Eq. 4)
The free energy of solvation of HoU inwater was determined to
be24.17 kcal mol1 and would correspond to the free energy
of solvation for the neutral molecule when the solvent pH was
equal to the pKa of the 5-hydroxyl proton. The measured pKa
for the 5-hydroxyl group of 5-hydroxy-2-deoxyuridine is 7.6
(49), and the hSMUG1 experiments were performed at pH 8.0
and 37 °C.The corresponding correction factorwould be0.57
kcal mol1, so that the free energy of solvation for ionized HoU
would be24.75 and23.60 kcalmol1 for neutral HoU at pH
8.0. The value for the neutral species is recorded in Table 1.
Similarly, the free energy of solvation for neutral CaU was
calculated to be24.39 kcal mol1. The experimentally meas-
ured value for the pKa of the 5-carboxyl proton reported here is
4.08. SinceCaUwould be expected to be predominantly ionized
at pH 8, a correction factor of 5.57 kcal mol1 would be
required. Since the neutral form of CaU would spontaneously
ionize at pH 8, the free energy of solvation of the ionized CaU
would be 29.95, whereas the free energy of solvation of the
neutral molecule at pH 8 would be 18.83 kcal mol1. The
value for the neutral molecule is recorded in Table 1.
A complex relationship between the observed enzymatic rate
constant (kobs) and the SASA was observed and is presented in
Fig. 5. The natural logarithm of the observed rate constant (ln
kobs) was observed to decrease linearly with increasing SASA
for a subset of the analogs examined (Fig. 5, inset). The observed
enzymatic rate constant (kobs) was also observed to decrease
linearly for several of the pyrimidine analogs except uracil as the
magnitude of the free energy of solvation in water (Gsolv0 ) for
the corresponding pyrimidine became less favorable (Fig. 6).
Further relationships between the properties of the analogs
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FIGURE 3. Linear relationship between the free energy of duplex forma-
tion,Gduplex, and observed cleavage rate constants.MUGdata fromRef.
52 is presented as squares, andhSMUG1 from this study is presented as circles.
The natural logarithms of the observed rate constants (ln kobs) for MUG and
hSMUG1 are plotted versus Gduplex. Straight lines are obtained for hSMUG1
with a slope of 1.26, intercept of 12.35, and r2 0.96 and forMUGwith a slope
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examined and the observed cleavage rate constants were
explored and are presented under “Discussion.”
DISCUSSION
Human single strand selective monofunctional uracil-DNA
glycosylase, hSMUG1, is one of three glycosylases encoded on
human chromosome 12 that removes uracil from DNA. Like
the other two glycosylases, UNG and TDG, hSMUG1 is a
monofunctional glycosylase, generating an abasic site in the
initiation of the base excision repair pathway essential formain-
taining genomic integrity (1–4). Although UNG, TDG, and
hSMUG1 share many similarities, there are significant differ-
ences in the range of damaged and modified bases acted upon
by these enzymes, suggesting that they may have unique phys-
iological roles in genome maintenance. In the experiments
described here, we wished to examine more extensively the
potential substrates for hSMUG1 and to determine the mech-
anisms by which hSMUG1 locates and interrogates potential
substrates.
In order to accomplish this goal, a series of oligonucleotides
(Fig. 1) containing purine and pyrimidine analogs were con-
structed and characterized using standard methods (30) (see
Fig. 2 of Ref. 52 for structures of modified purines paired with
uracil). Duplex stability was determined bymeasuring the tem-
perature dependence of the oligonucleotide UV absorbance at
260 nm in aqueous solution as a function of oligonucleotide
concentration (Table 1). Several properties of the potential ura-
cil analog substrates were determined either experimentally or
computationally, as presented in Table 1 and discussed further
below. The human DNA repair enzyme, hSMUG1, was cloned
and purified as previously reported (13) and characterized by
MALDI-TOF mass spectrometry. The capacity of hSMUG1 to
cleave uracil and its analogs from duplex substrates was meas-
ured in single-turnover kinetic assays as shown in Fig. 2. Cata-
lytic rate constants are presented in Table 1. Previous studies
have established that E. coliMUG and hSMUG1 bind tightly to
the abasic site-containing oligonucleotide following the
removal of a target base (13, 14, 52). Due to the strong product
binding displayed by some glycosylases, steady-state kinetic
analysis does not give an accurate reflection of relative rates
with different potential substrates. Single-turnover kinetic con-
ditions are therefore required. Our preliminary studies with
hSMUG1 also indicated strong product binding, and therefore
the kinetic studies performed here were conducted under sin-
gle-turnover conditions.
In our previous study of a related glycosylase, E. coli MUG,
three parameters were identified that are used by MUG to
select a target pyrimidine (52). These factors were 1) duplex
stability (pyrimidines in less stable duplex structures were
repaired faster), 2) 5-substituent size (pyrimidine analogs with
smaller 5-substituents were repaired faster than those with
larger substituents), and 3) 5-substituent electronic inductive
effects (pyrimidines with electron-withdrawing substituents in
the 5-position were repaired faster than those with electron-
donating substituents). Based upon the similarities in the enzy-
matic properties of MUG and hSMUG1, it was expected that
hSMUG1would use similar strategies for substrate selection. In
this study with hSMUG1, we have used the same battery of
oligonucleotide substrates to probe the mechanisms of base
selection, and we have added additional analogs reported to be
repaired by hSMUG1, including a series of pyrimidines oxi-
dized in the 5-position, including HmU, FoU, CaU, and HoU.
In the first study with hSMUG1, the repair of a target uracil
residue paired opposite a series of purine analogs was exam-
ined. The purines selected would allow simultaneous assess-
ment of the potential impact of the purine on duplex stability
and could probe for the importance of specific functional
groups. Within this series, the target uracil could be found in a
base pair configuration similar to a Watson-Crick base pair
with one (U:Pu), two (U:A, U:2APu), or three (U:AA) hydrogen
bonds or mispaired in a wobble geometry with two hydrogen
bonds (U:G, U:Hx). The thermodynamic stability of the uracil-
containing oligonucleotides within this series varies signifi-
cantly, as indicated in Table 1.
The single-turnover kinetics for the repair of uracil within
this series of duplex oligonucleotides was measured, and the
observed rate constants (kobs) are presented in Table 1. Inspec-
tion of the data indicates that the observed rate constants
decline as the free energy of duplex formation increases. Note
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FIGURE 5. Relationship between SASA and glycosylase kinetics. The
observed rate constants (kobs) for hSMUG1 cleavage of uracil analogs paired
opposite guanine are plotted against the SASA. Inset, the impact of the size
aloneon theapparent rate constant. In the inset, valuesof ln kobs forU:G, FU:G,
and ClU:G are plotted versus SASA. A straight line is obtained, with slope of
0.27, intercept of 69.19, and r2 0.99.
FIGURE 6. Relationship between glycosylase cleavage rates andG0 sol-
vation. The observed rate constants (kobs) for hSMUG1 cleavage of uracil
analogs opposite guanine are plotted against G0 solvation. A line is drawn
throughall thepoints except uracil. The slopeof this line is5.58	103with
intercept of8.96	 102, and r2 is 0.90.
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that a larger negative value for the free energy of duplex forma-
tion (Gduplex) indicates greater duplex stability. A plot of the
natural logarithm of the observed rate constant versus the free
energy of duplex formation is shown in Fig. 3. The line describ-
ing the data for the six uracil-containing base pairs is indicated
in Equation 5,
lnkobs 1.26Gduplex 12.35 (Eq. 5)
A predicted rate constant (kduplex), based upon the measured
helix stability (Gduplex), can then be determined (Equation 6).
In order to compare rate constants based upon additional
parameters described below, a relative rate constant (krel,duplex)
can be calculated (Equation 7). A predicted rate constant is
converted to a predicted relative rate constant by dividing
kduplex by the rate constant for theU:G pair given by Equation 6.
Because the U:G pair is common to both sets of oligonucleo-
tides used here, the rate constant for the U:G pair is used to
normalize each data set.
kduplex 2.30	 10
5e1.26Gduplex (Eq. 6)
krel,duplex 8.48	 10
5e1.26Gduplex (Eq. 7)
Enzyme cleavage data previously reported for MUG is pre-
sented with data obtained in this study with hSMUG1 (Fig. 3)
using a common series of oligonucleotide substrates containing
purine analogs opposite the target uracil. Linear relationships
between ln kobs and Gduplex are observed for both MUG and
hSMUG1; however, the slope of the line is greater for the
hSMUG1 data. Within the same sequence context, MUG
removes uracil mispaired with guanine 25 times faster than
uracil paired with adenine (52), whereas the mispaired uracil is
repaired 223 times faster by hSMUG1, indicating that hSMUG1
is more selective than MUG for mispaired structures. Within
the CpG/A dinucleotide sequence examine here, TDG is
reported to cleave U:G 788 times faster than U:A (19). The
mechanism for TDG selectivity has not yet been reported.
The known glycosylases flip the target base from the duplex
into a pyrimidine binding pocket within the enzyme prior to
hydrolysis of the glycosidic bond (5). Although the energetics of
base flipping by the glycosylase are not the same as duplexmelt-
ing, we believe that melting differences observed within a
homologous series of oligonucleotides do provide a reasonable
estimate of the impact of specific base substitutions on the
energy cost of removing a base from the duplex. An alternative
theory is that the glycosylase can distinguish uracil mispaired
with guanine from uracil paired with adenine by interrogating
functional groups of the purine remaining in the duplex follow-
ing extrusion of the target uracil, as suggested for MUG (55).
Within the series of purines examined here, removal of the
guanine 2-amino group, forming the U:Hx base pair,
enhanced rather than diminished the rate of uracil cleavage.
Removal of the 6-oxygen and the 2-amino group, which also
changes the N1 position from a hydrogen bond donor to an
acceptor (U:G to U:Pu), reduces cleavage rates only mod-
estly. The data reported here indicate that hSMUG1 proba-
bly exploits the reduced stability of mispairs in its search for
target bases. The data reported here cannot determine
whether hSMUG1 scans for extruded bases or tests for
reduced stability of duplex structures.
An additional and somewhat unique physiological role pro-
posed for hSMUG1 is the repair of damaged bases arising from
oxidation of the thymine methyl group. Previous studies have
demonstrated that hSMUG1can recognize and remove the oxi-
dation damage products, HmU and FoU (15–18). In this study,
we have examined for the first time the capacity of hSMUG1 to
remove CaU, the last in the series of thymine methyl group
oxidation products (Fig. 2 and Table 1). As demonstrated here,
hSMUG1 efficiently cleaves CaU, extending its substrate range
and further confirming its role in the repair of DNA oxidation
damage. In order to more fully understand CaU, its ionization
constants were measured as shown in Fig. 4. The capacity of
hSMUG1 to select oxidized bases over thymine is remarkable
and has been previously attributed to water molecules within
the pyrimidine binding pocket of the glycosylase that could be
displaced by uracil analogswith hydrogen bonding substituents
in the 5-position but not by the thyminemethyl group (14–18).
In the studies reported here, we have attempted tomore fully
understand the mechanism by which hSMUG1 distinguishes
among 5-substituted uracil analogs. Previous studies with both
MUG and TDG have demonstrated that a substituent in the
5-position of the uracil analog could have a profound impact on
the glycosylase cleavage rate (52, 56). In our studies withMUG,
we demonstrated that smaller and more electron-withdrawing
substituents facilitated cleavage, whereas larger and more elec-
tron-donating substituents had the opposite effect. We there-
fore examined hSMUG1 cleavage of a series of 5-substituted
uracil analogs mispaired with guanine. As shown in Table 1,
hSMUG1 is observed to cleave mispaired FU:G 29 times more
slowly than U:G. This was a surprising finding, since MUG
cleaves FU 4.8 times faster than U (52), and TDG cleaves FU 78
times faster that U (19). The selective cleavage of FU:G over
U:G by MUG was attributed to the electron-withdrawing
5-fluoro substituent that could potentially stabilize the glyco-
sylase transition state (52). The observation reported here with
hSMUG1, however, suggests that the inductive properties of
the 5-substituent are not utilized by hSMUG1 for target selec-
tion, and therefore the hSMUG1 transition state could diverge
significantly fromMUG and TDG.
Substituent size was shown to be a significant factor for base
selection by MUG, and we wished to test the importance of
substituent size with hSMUG1 as well. In the previous study,
however, we examined only spherical 5-substituents, the size of
which could be estimated from published bond lengths and van
der Waals radii. In order to include the additional oxidation
products HmU, FoU, CaU, and HoU in the analysis, an alterna-
tive method was needed to estimate the size of the various
5-substituents. We therefore calculated the SASA for each of
the pyrimidines examined here, as shown in Table 1. All of
the pyrimidines examined here are 5-substituted uracil ana-
logs or uracil. Differences in the calculated SASA within this
series can be attributed to relative differences in the size of
the 5-substituent.
The activity of hSMUG1 against uracil and each of the 5-sub-
stituted pyrimidines paired with guanine was measured, and
the observed rate constants are recorded in Table 1. Observed
hSMUG1 Substrate Selectivity
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rate constants are plotted versus SASA, as shown in Fig. 5.
Inspection of the data in this figure indicates that the observed
rate constant is not a simple function of the SASA. The magni-
tude of the rate constant declines with increasing SASA for
most of the analogs. However, for the oxidation damage prod-
ucts derived from thymine (FoU, CaU, and HmU) rate con-
stants increase with increasing SASA.
Measurable rate constants were obtained for U:G, FU:G, and
ClU:G (Table 1). No cleavage was detected for T, BrU, or IU.
Unlike the oxidation damage products, the halogen substitu-
ents would not readily form hydrogen bonds with water mole-
cules or pyrimidine binding pocket amino acid residues and
were therefore used to estimate the impact of size alone on the
apparent rate constants. When the ln kobs is plotted versus
SASA for U:G, FU:G, and ClU:G, a straight line is obtained (Fig.
5, inset) with slope0.27 and intercept 69.19. The correlation
coefficient (r2) with these three data points is 0.99.
The natural logarithm of the rate constant as a function of
size, based upon the data presented in Fig. 5 (inset) is expressed
as Equation 8. The rate constant (kSASA) for a uracil analog with
known SASA can then be predicted by Equation 9.
lnkobs 0.27	 SASA 69.19 (Eq. 8)
kSASA e
0.27	 SASA 69.19 (Eq. 9)
Within the U, FU, and ClU series, the FU and ClU analogs have
similar electron-withdrawing properties, but the U hydrogen
substituent is neither electron-withdrawing nor electron-do-
nating. With MUG, the observed rate constant dropped by a
factor of 3 from FU to ClU, and this drop was attributed to the
increased size of Cl relative to F. With hSMUG1, the observed
rate constant drops by a factor of 52 fromFU toClU. Therefore,
the pyrimidine binding pocket of hSMUG1 ismuch tighterwith
respect to the size of the substituent alone, and the rate con-
stant drops exponentially with increasing substituent size
(SASA). The observed rate constants for the series U, FU, ClU
drop exponentially with increasing SASA, as shown in the inset
of Fig. 5. Cleavage was undetectable for T, BrU, and IU. The
exponential decline of kobs for U, FU, and ClU with increasing
SASA confirms the absence of an influence of substituent
inductive effect, as discussed above.
Previous enzymatic and structural studies have discussed the
capacity of hSMUG1 to recognize and cleave oxidation damage
products like HmU. It is amazing that the hSMUG1 could
cleave U, avoid T, and cleave the larger HmU. The pyrimidine
binding pocket of SMUG1 has bound water molecules that
form hydrogen bonds with amino acid residues lining the
pocket. It has been proposed that the hydroxymethyl group of
HmU could displace the bound water molecules and form
hydrogen bonds with the pocket whereas this would not be
possible with the thymine methyl group (13–18). The
hydroxymethyl group of HmU is hydrophilic, whereas the thy-
mine methyl group is hydrophobic.
In order to further understand the substituents that could
form potential hydrogen bonds, we sought a parameter that
could distinguish substituents that favorably interact with
water from those that did not, such as the thymine methyl
group. We therefore calculated the free energy of solvation in
water (Gsolv0 ) for each of the pyrimidines examined here, the
results of which are recorded in Table 1. The magnitude of the
free energy of solvation is greater for hydrophilic compounds
(larger, negative values are more favorable), and these values
become smaller in magnitude and approach zero for more
hydrophobic compounds. Within the series of uracil analogs
examined here, differences in Gsolv0 can be attributed to the
effect of the 5-substituent, since the remainder of the molecule
remains constant.
Observed rate constants are plotted versus the free energy of
solvation for each pyrimidine in Fig. 6. Rate constants decline as
the free energy of solvation in water diminishes in magnitude,
and rate constants approach zero when Gsolv0 declines to
approximately 16 kcal mol1. The solvation free energy for
the ClU analog is 16.6 kcal mol1, and the observed enzy-
matic rate constant is the lowest observed. The solvation free
energy for the BrU, T, and IU analogs is less favorable than
16.6 kcal mol1 (Table 1), consistent with no observable
enzyme cleavage. The parent pyrimidine uracil does not fall on
this line. The 5-hydrogen of uracil is the smallest possible sub-
stituent; therefore, size rather than the free energy of solvation
might dominate its enzymatic rate constant.
The equation for the line in Fig. 6, relating the observed rate
constant with the solvation free energy for the analog is given as
Equation 10.
kGsolv0 5.58	 10
3Gsolv
0  8.96	 102 (Eq. 10)
The free energy of solvation in water reasonably accounts for
the differences in the observed rate constants for several of the
analogs recognized by hSMUG1. Analogs with substituents
that interact well withwater wouldmore easily displace or rear-
range bound water molecules, forming hydrogen bonds with
amino acid residues or bound water molecules. Themodel pre-
sented here does not represent a significant departure from
previous proposals on the selectivity of hSMUG1 (14–17).
Rather, the difference between ourmodel and previous propos-
als is that we do not require any specific hydrogen bonds
between the substituent and the enzyme. Instead, we allow the
substituent to move, replace, or displace the bound water mol-
ecules in any manner that minimizes the free energy of the
system.We believe the data presented here support this model.
The analogs U, FU, and ClU have the most similar solvation
free energy but differ significantly in size, allowing isolation of
the impact of substituent size on observed cleavage rate con-
stants (Equation 9). However, for the remaining analogs, it is
not possible to isolate size and solvation free energy. We
therefore constructed an equation combining both proper-
ties to provide a predicted rate constant for the 5-substitu-
ent, ksubstituent, which is a function of both SASA and the free
energy of solvation (Equation 11).
ksubstituent kSASA kGsolv0 (Eq. 11)
In this equation, rate constants fall exponentially with increas-
ing SASA and increase linearly with increasing water solvation
free energy. In order to compare this data set with the previous
data set examining the free energy of duplex formation (Equa-
tion 7), the predicted rate constant, krel,substituent, relative to the
hSMUG1 Substrate Selectivity
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U:G pair, can be calculated by normalizing to the value pre-
dicted for U:G according to Equation 11. The relative rate con-
stant predicted based upon the combined effects of size (SASA)
and free energy of solvation for the substituent, krel,substituent,
can be expressed as Equation 12.
krel,substituent ksubstituent/0.118 (Eq. 12)
The comparison of the observed and expected rate constants,
combining both size and solvation energy according to Equa-
tion 12 is shown in Fig. 7. Good agreement between the
expected and observed values is obtained, indicating that Equa-
tion 11 reasonably describes the characteristics for a uracil ana-
log that most importantly influence enzymatic rate constants.
The above consideration of the impact of size and solvation
free energy has not yet accounted for differences in the free
energy of duplex formation. Within the series of uracil analogs
paired with guanine, observed melting temperatures vary from
50.4 to 46.3 °C, and free energy of duplex formation varies from
11.1 to 9.5 kcal mol1, as shown in Table 1. Although dif-
ferences in the free energy of duplex formation between paired
and mispaired structures are significantly larger than differ-
ences between the uracil analogs paired with guanine, we
wished to combine the parameters examined here.
In order to combine the substituent effect with the duplex
stability effect, the relative rate constants, normalized to the
U:G mispair present in each set, were combined to provide an
equation that would predict the rate constant for each of the
base pairs examined here as functions of its free energy of
duplex formation (Gduplex), free energy of solvation in water
(Gsolv0 ), and SASA, as given by Equation 13.
krel,expected krel,duplexkrel,substituent (Eq. 13)
The observed relative enzyme rate constants (krel,observed) for
the series of mispairs containing damaged bases examined in
this study are as follows: U:GHoU:GHmU:G CaU:G
FoU:G  FU:G  ClU:G  BrU:G, IU:G, T:G. The cleavage
rates for BrU:G, IU:G, andT:Gwere below the limit of detection
for the experimental methods used here. The expected relative
rate constants (krel,expected) based upon the model presented
here are as follows: FoU:G U:GHoU:GHmU:G CaU:
GFU:GClU:GBrU:G IU:GT:G.With the exception
of FoU:G, the model accurately predicts the relative rate con-
stants for the series.
The expected rate constants, determined with Equation 13
and the parameters presented inTable 1, are comparedwith the
observed relative rate constants in Fig. 8. Most of the points fall
on a line; however, the expected cleavage rate constants as pre-
dicted by the model are higher than the relative observed rates
for FoU:G and HoU:G. The unusual feature of both the FoU:G
and HoU:G base pairs is that the free energy of duplex forma-
tion for both is lower than for the U:G base pair (Table 1). A
previous study has confirmed that substitution with FoU con-
siderably lowers oligonucleotide melting temperatures, con-
sistent with the results reported here (57).
We noted that when the expected and observed rates were
compared, based upon the substituent effects alone (Fig. 7) and
not including duplex energy, all points fell on a line. However,
when duplex stability was included (Fig. 8), the points for
FoU:G andHoU:G deviate from a line describing the other base
pairs examined. A potential explanation for the apparent
anomalous behavior of the FoU:G and HoU:G is that reduced
duplex stability increases enzyme rate constants only to a point
and that further reduction of duplex stability provides no addi-
tional advantage for the enzyme. If the rate of pyrimidine extru-
sion has reached amaximum value when duplex stability drops
to that of theU:Gmispair, another step along the reaction coor-
dinate, such as the rate of glycosidic bond cleavage, might
become rate-limiting. Alternatively, the energetics of duplex
melting might differ from the energetics of enzymatic base
0
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FIGURE7.Thecomparisonofobserved rate constants (kobs) andexpected
rate constants based upon substituent characteristics (ksubstituent). The
observed rate is plotted against the expected rate based upon Equation 11. A
straight line is obtained, with slope of 0.83, intercept of 0.01, and r2 0.97.
FIGURE8.Relationshipbetweenobservedrelative rateconstants (krel,obs)
and expected relative rate constants based on duplex formation energy
of the oligonucleotide, size, and free energy of solvation of the uracil
5-substituent (krel,expected). The expected relative rates are calculated with
respect to the rate of cleavage of the U:G base pair according to Equation 13.
A straight line is obtained for several of the analogs with slope of 0.98, inter-
cept of 9.20	 103, and r2 0.99. Values for the FoU:G and HoU:G pairs do
not fall on this line.
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extrusion with some modified base pairs due to additional
chemical properties. In the study reported here, both SASA and
Gsolv0 were calculated for the major conformations of the neu-
tral species. Both FoU and HoU have pKa values near physio-
logical pH, and the enzyme active site might alter pKa values,
and substituents may be found in multiple conformations.
In summary, we have extended the substrate range of
hSMUG1 to include CaU, the last in the series of thymine
methyl group oxidation damage products. This result strength-
ens the suggested role for hSMUG1 in the repair of DNA oxi-
dation damage. Our results indicate that hSMUG1 distin-
guishes paired from mispaired uracil primarily on the basis of
reduced duplex stability for the mispair and that recognition of
specific functional groups on the purine in the opposing strand
contributes minimally. The most unique property of hSMUG1
is its capacity to cleave uracil but not thymine yet still cleave the
larger oxidation damage products. The preference of hSMUG1
for U:G over T:G can be attributed primarily to the greater size
of the Tmethyl group relative to the hydrogen of U. In contrast
to other glycosylases, hSMUG1 does not exploit the electronic
inductive property of the 5-substituent. The capacity to recog-
nize and repair HmU and other oxidized pyrimidines probably
resides in a pyrimidine-binding pocket on the enzyme. In
accordwith previousmodels, this pocket hasmobilewatermol-
ecules that can be displaced or rearranged to accommodate
some 5-substituents. Preferred substrates carry substituents
that can partially replace interactions with critical amino acid
residues vacated by the displaced or rearranged water mole-
cules. The model for selectivity toward the oxidized bases pre-
sented here does not differ conceptually from previous models,
based upon structural studies (15–18). Rather, we present a
parameter, the free energy of solvation in water (Gsolv0 ) that
can be used to reasonably describe in a quantitative manner
the favorable properties previously ascribed to the oxidized
base targets of hSMUG1. The exploitation of distinct chem-
ical properties of damaged andmodified bases and base pairs
by members of the uracil glycosylase family provides at the
same time necessary discrimination between normal and
damaged DNA and a broad spectrum of possible damage that
can be accommodated.
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